Metabolomic signatures associated with disease severity in multiple sclerosis
about
Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.Urinary Excretion of Aluminium and Silicon in Secondary Progressive Multiple Sclerosis.Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis.Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
P2860
Metabolomic signatures associated with disease severity in multiple sclerosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolomic signatures associated with disease severity in multiple sclerosis
@en
Metabolomic signatures associated with disease severity in multiple sclerosis.
@nl
type
label
Metabolomic signatures associated with disease severity in multiple sclerosis
@en
Metabolomic signatures associated with disease severity in multiple sclerosis.
@nl
prefLabel
Metabolomic signatures associated with disease severity in multiple sclerosis
@en
Metabolomic signatures associated with disease severity in multiple sclerosis.
@nl
P2093
P2860
P50
P1476
Metabolomic signatures associated with disease severity in multiple sclerosis
@en
P2093
Albert Saiz
Azucena Castro
Cristina Alonso
Ekaterina Kotelnikova
Ion Agirrezabal
Jose Carlos Alvarez-Cermeño
Manuel Comabella
Oscar Fernández
Pablo Villoslada
Rafael Arroyo
P2860
P356
10.1212/NXI.0000000000000321
P577
2017-01-27T00:00:00Z